<SEC-DOCUMENT>0001104659-24-005889.txt : 20240123
<SEC-HEADER>0001104659-24-005889.hdr.sgml : 20240123
<ACCEPTANCE-DATETIME>20240123161719
ACCESSION NUMBER:		0001104659-24-005889
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20240123
DATE AS OF CHANGE:		20240123
EFFECTIVENESS DATE:		20240123

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Armata Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0000921114
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				911549568
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-276657
		FILM NUMBER:		24552860

	BUSINESS ADDRESS:	
		STREET 1:		5005 MCCONNELL AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90066
		BUSINESS PHONE:		310-665-2928

	MAIL ADDRESS:	
		STREET 1:		5005 MCCONNELL AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90066

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AmpliPhi Biosciences Corp
		DATE OF NAME CHANGE:	20130222

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TARGETED GENETICS CORP /WA/
		DATE OF NAME CHANGE:	19940331
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>tm243762d1_s8.htm
<DESCRIPTION>FORM S-8
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM&nbsp;S-8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ARMATA PHARMACEUTICALS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Washington</B></FONT></TD>
    <TD STYLE="width: 50%; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>91-1549568</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(State or other jurisdiction of</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">incorporation or organization)<B>&nbsp;</B></P></TD>
    <TD STYLE="text-align: center">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(I.R.S. Employer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Identification No.)&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>5005 McConnell Avenue</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Los Angeles, CA 90066</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices) (Zip Code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Armata Pharmaceuticals,&nbsp;Inc. 2016 Equity
Incentive Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Armata Pharmaceuticals,&nbsp;Inc. 2016 Employee
Stock Purchase Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Full titles of the plans)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Armata Pharmaceuticals,&nbsp;Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>5005 McConnell Avenue</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Los Angeles, CA 90066</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name and address of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(310) 655-2928</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Telephone number, including area code, of agent
for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Copies to:</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding: 0.25pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Deborah L. Birx</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Armata Pharmaceuticals,&nbsp;Inc.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>5005 McConnell Avenue</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Los Angeles, CA 90066</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(310) 655-2928</B></P></TD>
    <TD STYLE="width: 50%; padding: 0.25pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Jared Fertman</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Willkie Farr&nbsp;&amp; Gallagher LLP</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>787 Seventh Avenue</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, New York 10019-6099</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(212) 728-8000</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of
&ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company&rdquo; and &ldquo;emerging growth
company&rdquo; in Rule&nbsp;12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 29%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large&nbsp;accelerated&nbsp;filer</FONT></TD>
    <TD STYLE="width: 16%"><FONT STYLE="font-family: Wingdings">&#168;</FONT><FONT STYLE="font-family: Wingdings; font-size: 10pt; color: #0070c0"></FONT></TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated&nbsp;filer</FONT></TD>
    <TD STYLE="width: 11%"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated filer</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#120;</FONT></FONT>&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller&nbsp;reporting&nbsp;company</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#120;</FONT></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company</FONT></TD>
    <TD><FONT STYLE="font-family: Wingdings">&#168;</FONT><FONT STYLE="font-family: Wingdings; font-size: 10pt; color: #0070c0"></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B)&nbsp;of the Securities Act. <FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE<BR>
REGISTRATION OF ADDITIONAL SHARES<BR>
PURSUANT TO GENERAL INSTRUCTION E</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to General Instruction
E to Form&nbsp;S-8, this Registration Statement on Form&nbsp;S-8 (this &ldquo;<U>Registration Statement</U>&rdquo;) is filed by Armata
Pharmaceuticals,&nbsp;Inc. (the &ldquo;<U>Registrant</U>&rdquo;) to register an additional 1,809,470 shares of the Registrant&rsquo;s
common stock, par value $0.01 per share (&ldquo;<U>Common Stock</U>&rdquo;), issuable under the Armata Pharmaceuticals,&nbsp;Inc. 2016
Equity Incentive Plan (the &ldquo;<U>Armata 2016 Plan</U>&rdquo;) or the Armata Pharmaceuticals,&nbsp;Inc. 2016 Employee Stock Purchase
Plan (the &ldquo;<U>Armata 2016 ESPP</U>&rdquo;).&nbsp; Such shares consist of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">(i)&nbsp;1,807,328 shares of Common Stock that were automatically added to the shares authorized for issuance
under the Armata 2016 Plan on January&nbsp;1, 2024, pursuant to an &ldquo;evergreen&rdquo; provision contained in the Armata 2016 Plan.
Pursuant to such &ldquo;evergreen&rdquo; provision, on January&nbsp;1st of each calendar year, from January&nbsp;1, 2017 through and including
January&nbsp;1, 2026, the number of shares authorized for issuance under the Armata 2016 Plan is automatically increased by: (a)&nbsp;a
number equal to 5% of the total number of shares of the Registrant&rsquo;s capital stock outstanding on December&nbsp;31st of the preceding
calendar year, or (b)&nbsp;a lesser number of shares determined by the Registrant&rsquo;s board of directors (the &ldquo;<U>Board</U>&rdquo;);
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">(i)&nbsp;2,142 shares of Common Stock that were automatically added to the shares authorized for issuance
under the Armata 2016 ESPP on January&nbsp;1, 2024, pursuant to an &ldquo;evergreen&rdquo; provision contained in the Armata 2016 ESPP.
Pursuant to such provision, on January&nbsp;1st of each calendar year, from January&nbsp;1, 2017 through and including January&nbsp;1,
2026, the number of shares authorized for issuance under the Armata 2016 ESPP is automatically increased by a number equal to the least
of: (a)&nbsp;1% of the total number of shares of the Registrant&rsquo;s capital stock outstanding on December&nbsp;31st of the preceding
calendar year; (b)&nbsp;2,142 shares; or (c)&nbsp;a number determined by the Board that is less than (a)&nbsp;and (b).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">This
Registration Statement hereby incorporates by reference the contents of the Registrant&rsquo;s registration statement on Form&nbsp;S-8
filed with the Commission</FONT> on <A HREF="https://www.sec.gov/Archives/edgar/data/921114/000110465923118799/tm2330738d1_s8.htm" STYLE="-sec-extract: exhibit">November&nbsp;15, 2023 (File No.&nbsp;333-275580)</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/921114/000114420416109313/v442756_s8.htm" STYLE="-sec-extract: exhibit">June&nbsp;22, 2016 (File No.&nbsp;333-212183)</A>,
<A HREF="https://www.sec.gov/Archives/edgar/data/921114/000114420417023433/v465550_s-8.htm" STYLE="-sec-extract: exhibit">May&nbsp;1, 2017 (File No.&nbsp;333-217563)</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/921114/000114420417059121/tv479430_s-8.htm" STYLE="-sec-extract: exhibit">November&nbsp;14, 2017 (File No.&nbsp;333-221564)</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/921114/000114420418017547/tv489683_s8.htm" STYLE="-sec-extract: exhibit">March&nbsp;28, 2018 (File No.&nbsp;333-223987)</A>,
and <A HREF="https://www.sec.gov/Archives/edgar/data/921114/000114420419030481/tv523249_s-8.htm" STYLE="-sec-extract: exhibit">June&nbsp;10, 2019 (File No.&nbsp;333-232058)</A>, respectively&nbsp;(the &ldquo;<U>Prior Registration Statements</U>&rdquo;), in each
case, <FONT STYLE="background-color: white">to the extent not superseded hereby. </FONT>The additional shares of Common Stock being registered
by this Registration Statement are of the same class as those securities registered on the Prior Registration Statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART&nbsp;I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION REQUIRED IN THE SECTION&nbsp;10(a)&nbsp;PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All information required by
Part&nbsp;I to be contained in the prospectus is omitted from this Registration Statement in accordance with Section&nbsp;428 of the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;) and the instructions to Form&nbsp;S-8 and instead will be delivered,
pursuant to Rule&nbsp;428 under the Securities Act, to each participant in the Armata 2016 Plan and the Armata 2016 ESPP, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART&nbsp;II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item 3.</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incorporation of Documents By Reference</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Registration Statement
is being filed for the purpose of increasing the number of securities of the same class as other securities for which Registration Statements
of the Registrant on Form&nbsp;S-8 relating to the same employee benefit plan are effective. Pursuant to General Instruction E to Form&nbsp;S-8,
this Registration Statement hereby incorporates by reference the contents of the Registration Statements referenced above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following documents, which we have filed with
the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;), are incorporated by reference in this registration statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/921114/000155837023004014/armp-20221231x10k.htm" STYLE="-sec-extract: exhibit">The Registrant&rsquo;s Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2022, filed with the Commission on March&nbsp;16, 2023;</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Registrant&rsquo;s Quarterly Reports on Form&nbsp;10-Q for the fiscal quarters ended March&nbsp;31, 2023, June&nbsp;30, 2023 and September&nbsp;30, 2023, filed with the Commission on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/921114/000155837023009372/armp-20230331x10q.htm" STYLE="-sec-extract: exhibit">May&nbsp;11, 2023</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/921114/000155837023014701/armp-20230630x10q.htm" STYLE="-sec-extract: exhibit">August&nbsp;14, 2023</A> and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/921114/000155837023019036/armp-20230930x10q.htm" STYLE="-sec-extract: exhibit">November&nbsp;14, 2023;</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/921114/000110465923083456/tm232384-1_pre14a.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Registrant&rsquo;s Preliminary Proxy Statement on Schedule 14A, filed with the Commission on </FONT>July&nbsp;24, 2023 (as amended and supplemented);</A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Registrant&rsquo;s Current Reports on Form&nbsp;8-K, filed with the Commission </FONT>on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/921114/000110465923002496/tm232848d1_8k.htm" STYLE="-sec-extract: exhibit">January&nbsp;10, 2023</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/921114/000110465923056598/tm2313321d1_8k.htm" STYLE="-sec-extract: exhibit">May&nbsp;5, 2023</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/921114/000110465923079822/tm2321012d1_8k.htm" STYLE="-sec-extract: exhibit">July&nbsp;11, 2023</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/921114/000110465923082362/tm2321631d1_8k.htm" STYLE="-sec-extract: exhibit">July&nbsp;19, 2023</A> and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/921114/000110465923102132/tm2326466d1_8k.htm" STYLE="-sec-extract: exhibit">September&nbsp;20, 2023</A>; and</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/921114/000114420415050355/v418421_8a12b.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The description of our common stock contained in our registration statement on Form&nbsp;8-A, filed with the Commission on </FONT>August&nbsp;18, 2015, including all amendments and reports filed for the purpose of updating such description.</A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All documents subsequently
filed by the Registrant pursuant to Sections 13(a), 13(c), 14, and 15(d)&nbsp;of the Securities Exchange Act of 1934, as amended, prior
to the filing of a post-effective amendment that indicates that all shares of common stock offered hereby have been sold or which deregisters
all shares of common stock then remaining unsold, shall be deemed to be incorporated by reference in this registration statement and to
be part hereof from the date of filing of such documents; <I>provided</I>, <I>however</I>, that documents or information deemed to have
been furnished and not filed in accordance with Commission rules&nbsp;shall not be deemed incorporated by reference into this registration
statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any statement contained herein
or in a document, all or a portion of which is incorporated or deemed to be incorporated by reference herein, shall be deemed to be modified
or superseded for purposes of this registration statement to the extent that a statement contained herein or in any other subsequently
filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement
so modified or superseded shall not be deemed, except as so modified or amended, to constitute a part of this registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item 8.</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibits.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following exhibits are filed herewith:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; padding: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit&nbsp;Description</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: justify; width: 7%"><A HREF="https://www.sec.gov/Archives/edgar/data/921114/000110465920040578/tm2014179d1_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify; width: 91%"><A HREF="https://www.sec.gov/Archives/edgar/data/921114/000110465920040578/tm2014179d1_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles of Amendment to Articles of Incorporation of the Company (effective March&nbsp;26, 2020) (incorporated by reference to Exhibit&nbsp;3.1 to the Company&rsquo;s Current Report on Form&nbsp;8-K, filed with the SEC on March&nbsp;30, 2020)</FONT>.</A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/921114/000155837019008168/armp-20190630ex35124c484.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/921114/000155837019008168/armp-20190630ex35124c484.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit&nbsp;3.5 to the Company&rsquo;s Quarterly Report on Form&nbsp;10-Q, filed with the SEC on August&nbsp;14, 2019)</FONT>.</A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/921114/000110465919071854/tm1924941d1_ex3-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/921114/000110465919071854/tm1924941d1_ex3-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit&nbsp;3.2 to the Company&rsquo;s Current Report on Form&nbsp;8-K, filed with the SEC on December&nbsp;11, 2019)</FONT>.</A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/921114/000110465920025375/tm2010968d1_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 1.5pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/921114/000110465920025375/tm2010968d1_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit&nbsp;3.1 to the Company&rsquo;s Current Report on Form&nbsp;8-K, filed with the SEC on February&nbsp;26, 2020)</FONT>.</A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: justify"><A HREF="tm243762d1_ex5-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify"><A HREF="tm243762d1_ex5-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Counsel</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: justify"><A HREF="tm243762d1_ex23-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify"><A HREF="tm243762d1_ex23-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Independent Registered Public Accounting Firm</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: justify"><A HREF="tm243762d1_ex5-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify"><A HREF="tm243762d1_ex5-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Counsel (included in Exhibit&nbsp;5.1 to this Registration Stated and filed herewith)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: justify"><A HREF="#s_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify"><A HREF="#s_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power of Attorney (included on the signature pages&nbsp;of this Registration Statement)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/921114/000114420419030481/tv523249_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/921114/000114420419030481/tv523249_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Armata Pharmaceuticals,&nbsp;Inc. 2016 Equity Incentive Plan, as amended (incorporated by reference to Exhibit&nbsp;99.1 to the registrant&rsquo;s Registration Statement on Form&nbsp;S-8, filed with the SEC on June&nbsp;10, 2019).</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/921114/000155837019008168/armp-20190630ex1010ab7df.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/921114/000155837019008168/armp-20190630ex1010ab7df.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Armata Pharmaceuticals,&nbsp;Inc. 2016 Employee Stock Purchase Plan (incorporated herein by reference to Exhibit&nbsp;10.10 to the Quarterly Report on Form&nbsp;10-Q, filed with the SEC on August&nbsp;14, 2019).</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: justify"><A HREF="tm243762d1_ex-filingfees.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: justify"><A HREF="tm243762d1_ex-filingfees.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing Fee Table</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="s_001"></A>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing
on Form&nbsp;S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in the City of Los Angeles, State of California  on <FONT>January 23</FONT>, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Armata Pharmaceuticals,&nbsp;Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 3%; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 47%; border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Deborah L. Birx</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deborah L. Birx&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Know
All Persons By These Presents</B></FONT><FONT STYLE="font-variant: small-caps">,</FONT> that each person whose signature appears below
constitutes and appoints each of Deborah L. Birx and Richard Rychlik as his or her true and lawful attorney-in-fact and agent, with full
power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any
and all amendments to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection
therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power
and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all
intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents,
or either of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 31%; border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURE</B></FONT></TD>
    <TD STYLE="width: 1%; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42%; border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TITLE</B></FONT></TD>
    <TD STYLE="width: 1%; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 25%; border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DATE</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Deborah L. Birx</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive
    Officer and a Director</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">January 23, 2024</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deborah
    L. Birx</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Principal
    Executive Officer)</I></FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Richard Rychlik</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
    Controller</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">January 23, 2024</FONT></TD></TR>

<TR>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center; width: 31%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
    Rychlik</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center; width: 42%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Principal
    Financial Officer)</I></FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Robin C. Kramer</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chair
    of the Board of Directors</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">January 23, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robin
    C. Kramer</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Odysseas D. Kostas</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">January 23, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Odysseas
    D. Kostas, M.D.</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Jules Haimovitz</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">January 23, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jules
    Haimovitz</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Sarah J. Schlesinger</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">January 23, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sarah
    J. Schlesinger, M.D.</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Joseph M. Patti</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">January 23, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-top: black 0.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Joseph
    M. Patti, Ph.D.</FONT></P></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Todd C. Peterson</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">January 23, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-top: black 0.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Todd
    C. Peterson, Ph.D.</FONT></P></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>tm243762d1_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><IMG SRC="tm243762d1_ex5-1img01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">January&nbsp;23, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Armata Pharmaceuticals,&nbsp;Inc.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4503 Glencoe Avenue&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Marina del Rey, CA 90292</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have acted as special counsel
to Armata Pharmaceuticals,&nbsp;Inc., a Washington corporation (the &ldquo;<B>Company</B>&rdquo;) in connection with its Registration
Statement on Form&nbsp;S-8 (the &ldquo;<B>Registration Statement</B>&rdquo;) to be filed with the Securities and Exchange Commission (the
&ldquo;<B>Commission</B>&rdquo;) under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;) relating to the
proposed offering of up to 1,809,470 shares (&ldquo;<B>Shares</B>&rdquo;) of common stock, par value $0.01 per share (&ldquo;<B>Common
Stock</B>&rdquo;) of the Company, 1,807,328 of which are issuable pursuant to the Company&rsquo;s 2016 Equity Incentive Plan, as amended
(the &ldquo;<B>Equity Plan</B>&rdquo;), and 2,142 of which are issuable pursuant to the Company&rsquo;s 2016 Employee Stock Purchase Plan,
as amended (the &ldquo;<B>ESPP</B>&rdquo;, and together with the Equity Plan, the &ldquo;<B>Plans</B>&rdquo; and each a &ldquo;<B>Plan</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this opinion
letter, we have examined (i)&nbsp;the Company&rsquo;s Amended and Restated Articles of Incorporation dated May&nbsp;21, 2009, as amended
on February&nbsp;22, 2011, as amended on June&nbsp;26, 2013, as corrected on October&nbsp;23, 2013, as amended on January&nbsp;5, 2015,
as amended August&nbsp;3, 2015, as amended April&nbsp;21, 2017, as corrected November&nbsp;7, 2018, as amended December&nbsp;17, 2018,
as amended May&nbsp;9, 2019, as amended December&nbsp;10, 2019, as amended March&nbsp;31, 2020; (ii)&nbsp;the Company&rsquo;s Amended
and Restated Bylaws dated May&nbsp;9, 2019, as amended on December&nbsp;10, 2019, as amended on February&nbsp;24, 2020; (iii)&nbsp;the
Registration Statement and the exhibits thereto; (iv)&nbsp;the Equity Plan; (v)&nbsp;the ESPP; and (vi)&nbsp;such other corporate records,
written consents, certificates and other instruments as in our opinion are necessary or appropriate in connection with expressing the
opinions set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In our examination of the
aforesaid documents and in rendering the opinion expressed herein, we have, without independent inquiry or investigation, assumed that:
(i)&nbsp;all documents submitted to us as originals are authentic and complete; (ii)&nbsp;all documents submitted to us as copies (including
..pdfs) conform to authentic, complete originals; (iii)&nbsp;all documents filed as exhibits to the Registration Statement that have not
been executed will conform to the forms thereof; (iv)&nbsp;all signatures on all documents that we reviewed are genuine; (v)&nbsp;all
natural persons executing documents had and have the legal capacity to do so; (vi)&nbsp;all statements in certificates of public officials
and the officers of the Company that we reviewed were and are accurate; and (vii)&nbsp;all representations made by the Company as to matters
of fact in the documents that we reviewed were and are accurate. We have also assumed that any certificates or instruments representing
the Shares, including the applicable award or purchase agreements, when issued, will be executed by the Company and by officers of the
Company duly authorized to do so, and that the terms of the applicable award or purchase agreements will be consistent with the forms
of agreement approved by the Board. In rendering our opinion, we have also relied upon a Certificate of Existence dated January&nbsp;19,
2024, issued by the Washington Secretary of State with respect to the Company and representations and certifications made to us by the
Company, including without limitation representations in an Officer&rsquo;s Certificate addressed to us of even date herewith that, as
of the date of this letter, the Company has available a sufficient number of authorized shares of Common Stock that are not currently
outstanding or reserved for issuance under any other outstanding securities or plans of the Company, to enable the Company to issue and
deliver all of the Shares. This opinion letter is given, and all statements herein are made, in the context of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm243762d1_ex5-1img02.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based upon, subject to, and
limited by the foregoing, we are of the opinion that following (i)&nbsp;the effectiveness of the Registration Statement, (ii)&nbsp;the
issuance of Shares pursuant to the terms of the applicable Plan and applicable award or purchase agreement, (iii)&nbsp;receipt by the
Company of the consideration for the Shares specified in the applicable Plan and the applicable resolutions of the Board of Directors
of the Company (or a duly authorized committee of the Board of Directors of the Company) authorizing the grant and issuance thereof, and
(iv)&nbsp;the registration on the books of the transfer agent and registrar for the Shares in the name or on behalf of the holders thereof,
such Shares will be validly issued, fully paid, and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This opinion letter is rendered
as of the date hereof, and we disclaim any obligation to advise you of facts, circumstances, events, or developments that hereafter may
be brought to our attention and that may alter, affect, or modify the opinion expressed herein. Our opinion is expressly limited to the
matters set forth above and we render no opinion, whether by implication or otherwise, as to any matters beyond the matters expressly
set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This opinion letter is based
as to matters of law solely on the Washington Business Corporation Act, as amended. We do not express any opinion herein concerning any
law other than the corporate laws of the State of Washington. We assume no obligation to supplement this opinion letter if any applicable
law changes after the date hereof or if we become aware of any fact that might change the opinions expressed herein after the date hereof.
We express no opinion herein as to any other statutes, rules, or regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We hereby consent to the filing
of this opinion letter with the Commission as Exhibit&nbsp;5.1 to the Registration Statement. In giving this consent, we do not thereby
admit that we are within the category of persons whose consent is required under Section&nbsp;7 of the Act or the rules&nbsp;and regulations
of the Commission promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Lane Powell PC</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Lane Powell PC</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>tm243762d1_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Exhibit&nbsp;23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Consent of Independent
Registered Public Accounting Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We consent to the incorporation
by reference in the Registration Statement&nbsp;(Form&nbsp;S-8)&nbsp;pertaining to the 2016 Equity Incentive Plan and 2016 Employee Stock
Purchase Plan of Armata Pharmaceuticals,&nbsp;Inc. of our report dated March&nbsp;16, 2023, with respect to the consolidated financial
statements of Armata Pharmaceuticals,&nbsp;Inc. included in its Annual&nbsp;Report&nbsp;(Form&nbsp;10-K)&nbsp;for&nbsp;the year ended
December&nbsp;31, 2022, filed with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white">/s/ Ernst&nbsp;&amp; Young
LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">San Diego, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">January&nbsp;23, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="margin: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>tm243762d1_ex-filingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;107</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Calculation of Filing Fee Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form&nbsp;S-8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Form&nbsp;Type)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARMATA PHARMACEUTICALS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Table 1: Newly Registered Securities.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 2pt; border-top: Black 1pt solid; border-left: Black 1pt solid; width: 12%; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security<BR>
 Type</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 2pt; border-left: Black 1pt solid; border-top: Black 1pt solid; width: 12%; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security<BR>
Class&nbsp;Title</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 2pt; border-left: Black 1pt solid; border-top: Black 1pt solid; width: 12%; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee<BR>
Calculation<BR>
Rule</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 2pt; border-left: Black 1pt solid; border-top: Black 1pt solid; width: 12%; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount<BR>
to be<BR>
registered (1)</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 2pt; border-left: Black 1pt solid; border-top: Black 1pt solid; width: 12%; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed<BR>
maximum<BR>
offering<BR>
price per<BR>
share(3)</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 2pt; border-left: Black 1pt solid; border-top: Black 1pt solid; width: 18%; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum aggregate<BR>
offering price(3)</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 2pt; border-left: Black 1pt solid; border-top: Black 1pt solid; width: 10%; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee Rate</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 2pt; border-left: Black 1pt solid; border-top: Black 1pt solid; border-right: black 1pt solid; width: 12%; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount of<BR>
registration fee</B></FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 2pt; border-bottom: Black 1pt solid; border-left: Black 1pt solid; vertical-align: top; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock, par value $0.01 per share</FONT></TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">457(c)&nbsp;and 457(h)</FONT></TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,807,328</FONT><FONT STYLE="font-size: 10pt"><BR>
(2)</FONT></TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3.60 (3)</FONT></TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$6,506,380.80</FONT></TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00014760</FONT></TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; border-right: black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$960.34 (4)</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 2pt; vertical-align: bottom; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock, par value $0.01 per share</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 2pt; vertical-align: bottom; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">457(c)&nbsp;and 457(h)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 2pt; vertical-align: bottom; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,142 (5)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 2pt; vertical-align: bottom; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3.60 (3)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 2pt; vertical-align: bottom; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$7,711.20</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 2pt; vertical-align: bottom; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00014760</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 2pt; vertical-align: bottom; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1.13 (4)</FONT></TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="padding-right: 2pt; border-left: Black 1pt solid; vertical-align: top; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Offering Amount</FONT></TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; vertical-align: bottom; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; vertical-align: bottom; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; vertical-align: bottom; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; border-right: black 1pt solid; vertical-align: bottom; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$961.47</FONT></TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="padding-right: 2pt; border-left: Black 1pt solid; vertical-align: top; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Fee Offsets</FONT></TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; vertical-align: bottom; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; vertical-align: bottom; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; vertical-align: bottom; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; border-right: black 1pt solid; vertical-align: bottom; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0</FONT></TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="padding-right: 2pt; border-bottom: black 1pt solid; border-left: Black 1pt solid; vertical-align: top; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Fees Due</FONT></TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-left: 2pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2pt; border-left: Black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; padding-left: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$961.47</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to Rule&nbsp;416(a)&nbsp;under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), this Registration Statement shall also cover any additional shares of the registrant&rsquo;s Common Stock,</FONT> <FONT STYLE="font-size: 10pt">par value $0.01 per share (&ldquo;<U>Common Stock</U>&rdquo;) of Armata Pharmaceuticals,&nbsp;Inc. (the &ldquo;<U>Company</U>&rdquo;) that become issuable under the Armata Pharmaceuticals,&nbsp;Inc. 2016 Equity Incentive Plan (the &ldquo;<U>Armata 2016 Plan</U>&rdquo;) or the Armata Pharmaceuticals,&nbsp;Inc. 2016 Employee Stock Purchase Plan (the &ldquo;<U>Armata 2016 ESPP</U>&rdquo;) by reason of any future stock dividend, stock split, recapitalization or other similar adjustments of the outstanding Common Stock.</FONT></P>
                                    <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents 1,807,328 shares of Common Stock that were automatically added to the shares authorized for issuance under the Armata 2016 Plan on January&nbsp;1, 2024, pursuant to an &ldquo;evergreen&rdquo; provision contained in the Armata 2016 Plan. Pursuant to such &ldquo;evergreen&rdquo; provision, on January&nbsp;1st of each calendar year, from January&nbsp;1, 2017 through and including January&nbsp;1, 2026, the number of shares authorized for issuance under the Armata 2016 Plan is automatically increased by: (a)&nbsp;a number equal to 5% of the total number of shares of the Company&rsquo;s capital stock outstanding on December&nbsp;31st of the preceding calendar year, or (b)&nbsp;a lesser number of shares determined by the Company&rsquo;s board of directors (the &ldquo;<U>Board</U>&rdquo;).</FONT></P>
                                    <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated solely for purposes of calculating the amount of the registration fee, pursuant to Rules&nbsp;457(c)&nbsp;and 457(h)&nbsp;under the Securities Act, the proposed maximum aggregate offering price is the product obtained by multiplying (i)&nbsp;$3.60 (the average of the high and low prices of the Company&rsquo;s Common Stock on January&nbsp;18, 2024, as reported on the NYSE American) by (ii)&nbsp;1,809,470 (the number of shares of Common Stock issuable in connection with equity awards that may be granted in the future pursuant to the Armata 2016 Plan or the Armata 2016 ESPP).</FONT></P>
                                    <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount of registration fee is calculated only with respect to the additional shares of Common Stock registered on this Registration Statement. The existing securities issuable under the Armata 2016 Plan and Armata 2016 ESPP were registered, and the correlating registration fee paid, pursuant to the Registration Statements on Form&nbsp;S-8 filed on November&nbsp;15, 2023 (File No.&nbsp;333-275580), June&nbsp;22, 2016 (File No.&nbsp;333-212183), May&nbsp;1, 2017 (File No.&nbsp;333-217563), November&nbsp;14, 2017 (File No.&nbsp;333-221564), March&nbsp;28, 2018 (File No.&nbsp;333-223987), and June&nbsp;10, 2019 (File No.&nbsp;333-232058).</FONT></P>
                                    <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents 2,142 shares of Common Stock that were automatically added to the shares authorized for issuance under the Armata 2016 ESPP on January&nbsp;1, 2024, pursuant to an &ldquo;evergreen&rdquo; provision contained in the Armata 2016 ESPP. Pursuant to such provision, on January&nbsp;1st of each calendar year, from January&nbsp;1, 2017 through and including January&nbsp;1, 2026, the number of shares authorized for issuance under the Armata 2016 ESPP is automatically increased by a number equal to the least of: (a)&nbsp;1% of the total number of shares of the Company&rsquo;s capital stock outstanding on December&nbsp;31st of the preceding calendar year; (b)&nbsp;2,142 shares; or (c)&nbsp;a number determined by the Board that is less than (a)&nbsp;and (b).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Table 2: Fee Offset Claims and Sources</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm243762d1_ex5-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm243762d1_ex5-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !> +<# 2(  A$! Q$!_\0
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M^PJC,R?#RX34F[-?RD?H/Z459T2$Q:5$6'SR9E;ZL<_UHIL2,_QO_P B??\
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M8J(^'(A//+%?ZA!YTAD98I]J[CU.,57*U9J)'/%J493O>VMGT8WQ)_Q[6/\
MV$(/_0Q6Y63-H4<^GK:2W5VX642K*TN9 PY'.*(=#\F9)?[3U)]C ['N,J?8
MC'2FN92;MO8ENFX*/-M?IO<UJI:B/.C6T7.9C@X[+W-6R0JY/:HXHR7:5_O-
MP/8>E;',2JH50H& . **6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
= **** "BBB@ HHHH ;MW')_ 4ZBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm243762d1_ex5-1img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm243762d1_ex5-1img02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  W PT# 2(  A$! Q$!_\0
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M!M-:P$J3#$2O"DH./I3XHTA4J@ !8MCW)R?U)K!_M0_V^HDM;K!D^SPDP.%
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M,5"+2!9/,$,8?.=P09_.IZ* (Q"BR,ZHH=NK <FCR(_G^1?G^]Q][Z^M244
M0/9V\C;I((G;IED!-#6=N[[V@B9_[Q0$U/10!'Y*>9YFQ=^,;L<X^M'E)_=7
MKNZ=_6I** &/$D@ =58 Y&1GGUH>)'QO56P<C(S@T^B@!C1(S*6525.02.GT
MIV.,4M% #$C5"=JJ-QR<#&34<EI!*^^2&)V]60$U/10!&84)4E%)7[IQT^E*
M8D,@D*KO P&QS3Z* (6M87&'BC89S@H#SZTC6=NRJK01%5X4%!@?2IZ* (C;
MQ%%0QH57[JE1@?2G&)3G*J=PP<CJ*?10!$]O'*NV2-'4= PR*1+:&-&1(D56
MZJJ@ _45-10!'Y*;0NU=HQ@8X&.E2444 5Y+2WF</)#&[#H64$BGK!&@8*B@
M,<M@=3[U+12L!$D,<9RD:*<!>!C@=!3);2"?'FPQR8Z;E!Q5BBBP$4<,<9RB
M*IQMX';TH>".1@SHC%3E21G%2T46 3:",$#%(5'/ YIU%,"LEC;1DE+>)21@
MX0#(]*1;&U5&06\(5OO*$&#]:M44K(+L@2VAC"A(HU"\@*H&#[4Y8(UD,@10
MYX+ <G\:EHHL!$88S+YFQ=^,;L<X^M*8D9]Y5=V,9QSBI**+ ,6-49F50"W4
M@=:?113 0C(P:K+I]HBHJVT0";=N$'&W[N/IGBK+'"DFL;2]6^VWDT9D1E;]
MY"%ZA =O/Z-_P+VHM<+M&A]@M B)]GBV1@A!L&%!&#C\#37TVS>6*5K6(R1
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M>E/5%7.T 9.3BBB@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
@* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
